| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | Director | Common Stock | 178,000 | $366,680 | $2.06 | 02 Jan 2024 | Direct |
| Cartesian Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 228,000 | $180,120 | $0.7900 | 02 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | 02 Jan 2024 | 2 | $0 | 4 | Director | 04 Jan 2024, 17:07 |
| RNAC | Cartesian Therapeutics, Inc. | 13 Nov 2023 | 7 | -$69,750 | 4 | Director | 15 Nov 2023, 17:17 |
| RNAC | SELECTA BIOSCIENCES INC | 02 Jan 2023 | 1 | $0 | 4 | Director | 04 Jan 2023, 16:00 |
| RNAC | SELECTA BIOSCIENCES INC | 03 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 15:35 |